Nancy Anderson, MMSc, MT(ASCP), is the Senior Advisor for Clinical Laboratories, Division of Laboratory Systems at the Centers for Disease Control and Prevention (CDC). In this capacity she manages a number of CDC’s responsibilities under the Clinical Laboratory Improvement Amendments (CLIA) program that oversees medical laboratory testing in the United States in collaboration with the Centers for Medicare & Medicaid Services and the US Food and Drug Administration. Previously, she served as a Branch Chief in the same Division, with many of the same responsibilities she held in the CLIA program. She has contributed to developing quality standards for approximately 10 CLIA regulations and several guidelines promoting good laboratory practices. Ms. Anderson’s clinical laboratory experience includes her work in hospital laboratories in New York, Florida, and Georgia, in the CDC Special Bacteriology Reference Laboratory, and serving as the Coordinator for Emory University’s Master of Medical Science (MMSc) degree programs in the clinical laboratory sciences.
Ms. Anderson holds an MMSc degree in Clinical Microbiology from Emory University and is certified as a Medical Technologist by the American Society for Clinical Pathology. She is active in CLSI, where she chaired the subcommittee that developed M50, was a member of the document development committee for M52, and was a member of the Consensus Committee on Microbiology from 2009 to 2013.